BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17939344)

  • 1. Amiodarone-induced hepatitis and polyneuropathy.
    Kang HM; Kang YS; Kim SH; Seong JK; Kang DY; Lee HY; Lee BS
    Korean J Intern Med; 2007 Sep; 22(3):225-9. PubMed ID: 17939344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy.
    Lahbabi M; Aqodad N; Ibrahimi A; Lahlou M; Aqodad H
    World J Hepatol; 2012 Jun; 4(6):196-8. PubMed ID: 22761971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cirrhosis caused by low-dose oral amiodarone therapy.
    Puli SR; Fraley MA; Puli V; Kuperman AB; Alpert MA
    Am J Med Sci; 2005 Nov; 330(5):257-61. PubMed ID: 16284489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathy and fatal hepatitis in a patient receiving amiodarone.
    Lim PK; Trewby PN; Storey GC; Hole DW
    Br Med J (Clin Res Ed); 1984 Jun; 288(6431):1638-9. PubMed ID: 6326931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudo-alcoholic hepatitis and cirrhosis caused by amiodarone (Cordarone)].
    Lamproye A; Ramos J; Larrey D; Belaiche J
    Rev Med Liege; 1998 Mar; 53(3):121-4. PubMed ID: 9594610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced liver cirrhosis and parkinsonism: a case report.
    Ishida S; Sugino M; Hosokawa T; Sato T; Furutama D; Fukuda A; Kimura F; Kuwabara H; Shibayama Y; Hanafusa T
    Clin Neuropathol; 2010; 29(2):84-8. PubMed ID: 20175957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amiodarone-induced liver dysfunctions].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Jul; 135(27):1372-4. PubMed ID: 20589584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic dysfunction and neurotoxicity in a patient receiving long-term low-dose amiodarone therapy.
    Arkun A; Van Deusen SK; Grau T; Birkhahn RH
    J Emerg Med; 2010 Apr; 38(3):337-9. PubMed ID: 18757154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
    Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
    J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatotoxicity from intravenous amiodarone in a patient on hemodialysis].
    Bucco S; Arazzi M; Giunta F; Grabocka X; Longo MO; Silvestri S; Spetrino N; Tondo M; Vigilante G; Bonomini M
    G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
    Raja K; Thung SN; Fiel MI; Chang C
    Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone induced liver cirrhosis. Report of two cases.
    Atiq M; Davis JC; Lamps LW; Beland SS; Rose JE
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):233-5. PubMed ID: 19565059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism].
    Cho YS; Han JH; Chae HB; Kim JS; Kang KM; Park SM; Lim JC
    Korean J Gastroenterol; 2013 Jul; 62(1):59-63. PubMed ID: 23954962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatitis complicating intravenous amiodarone treatment.
    Agozzino F; Picca M; Pelosi G
    Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal acute-on-chronic liver failure in amiodarone-related steatohepatitis: a case report.
    Wu IU; Tsai JH; Ho CM
    BMC Gastroenterol; 2021 Feb; 21(1):50. PubMed ID: 33530924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
    Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
    Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granular cells as a marker of early amiodarone hepatotoxicity.
    Jain D; Bowlus CL; Anderson JM; Robert ME
    J Clin Gastroenterol; 2000 Oct; 31(3):241-3. PubMed ID: 11034006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can pancreatitis be associated with amiodarone hepatotoxicity?
    Sastri SV; Diaz-Arias AA; Marshall JB
    J Clin Gastroenterol; 1990 Feb; 12(1):70-3. PubMed ID: 1689330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.